New Drug Discovery and Development

1. Auflage 2006
ISBN: 978-0-470-00750-1
Verlag: Wiley

Buch, Englisch, 216 Seiten, Format (B × H): 162 mm x 235 mm, Gewicht: 467 g

A case history approach to drug synthesis and discovery

Discover the origins of some of today’s most popular drug therapies. Explore case histories and gain insight into major classes of antibiotics, antiviral drugs, analgesics, steroids, compounds designed to lower cholesterol, and more. Review the steps required for FDA approval. This is a great reference for students in medicinal chemistry, researchers in pharmaceuticals, and medical practitioners.

Autoren/Hrsg.

Lednicer, Daniel

Fachgebiete

• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Pharmazeutische Technologie
• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Kosmetische Technologie

Inhaltsverzeichnis

Preface.

1. Antibiotics.

2. Antiviral Drugs.

3. Antihypertensive Agents.

4. Lipid Lowering Drugs.

5. Centrally Acting Analgesics.

6. Nonopiate Analgesic Agents.

7. Steroids.

8. Histamine.

9. From Lab Bench to Pharmacy Shelf.

Appendix.

Index.

Über Autor(innen)

DANIEL LEDNICER, PhD, is the acclaimed author of several books on drug synthesis and discovery. His career in both the private and public sectors has been devoted to the search for new therapeutic agents. Dr. Lednicer spent two decades at the bench as a chemist at the Upjohn Company. Following that, he served as director of chemical research at Mead Johnson, director of pharmaceutical sciences at Adria Laboratories, and pharmaceutical manager at Analytical Biochemistry Laboratories. Most recently, he was a project officer at the National Cancer Institute.